Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcelo O Ortells

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Evolutionary Anthropology|August 12, 2025
The Multivariate Basis of Human Brain Evolution: The Prerequisites of Fire Control and CookingMarcelo O Ortells, Stephon Stewart
Proteins|August 21, 2007
A model for the assembly of nicotinic receptors based on subunit-subunit interactionsMarcelo O Ortells, Georgina E Barrantes
Medical Hypotheses|December 8, 2009
Tobacco addiction: a biochemical model of nicotine dependenceMarcelo O Ortells, Georgina E Barrantes
The International Journal of Biochemistry & Cell Biology|September 14, 2010
Neuronal networks of nicotine addictionMarcelo O Ortells, Hugo R Arias
Neurochemistry International|August 7, 2013
(-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sitesHugo R Arias, Marcelo O Ortells, Dominik Feuerbach
Neurochemistry International|September 11, 2016
Bupropion and its photoreactive analog (±)-SADU-3-72 interact with luminal and non-luminal sites at human α4β2 nicotinic acetylcholine receptorsHugo R Arias, Dominik Feuerbach, Marcelo O Ortells
The International Journal of Biochemistry & Cell Biology|January 19, 2010
Inhibitory mechanisms and binding site location for serotonin selective reuptake inhibitors on nicotinic acetylcholine receptorsHugo R Arias, Dominik Feuerbach, Pankaj Bhumireddy, et al.
Journal of Natural Products|July 6, 2019
Alkaloids Purified from <i>Aristotelia chilensis</i> Inhibit the Human α3β4 Nicotinic Acetylcholine Receptor with Higher Potencies Compared with the Human α4β2 and α7 SubtypesHugo R Arias, Marcelo O Ortells, Dominik Feuerbach, et al.
Molecules (Basel, Switzerland)|April 30, 2021
Is the Antidepressant Activity of Selective Serotonin Reuptake Inhibitors Mediated by Nicotinic Acetylcholine Receptors?Hugo R Arias, Katarzyna M Targowska-Duda, Jesús García-Colunga, et al.
Journal of Natural Products|April 11, 2018
Drimane Sesquiterpenoids Noncompetitively Inhibit Human α4β2 Nicotinic Acetylcholine Receptors with Higher Potency Compared to Human α3β4 and α7 SubtypesHugo R Arias, Dominik Feuerbach, Bernd Schmidt, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Evolutionary Anthropology|August 12, 2025
The Multivariate Basis of Human Brain Evolution: The Prerequisites of Fire Control and CookingMarcelo O Ortells, Stephon Stewart
Proteins|August 21, 2007
A model for the assembly of nicotinic receptors based on subunit-subunit interactionsMarcelo O Ortells, Georgina E Barrantes
Medical Hypotheses|December 8, 2009
Tobacco addiction: a biochemical model of nicotine dependenceMarcelo O Ortells, Georgina E Barrantes
The International Journal of Biochemistry & Cell Biology|September 14, 2010
Neuronal networks of nicotine addictionMarcelo O Ortells, Hugo R Arias
Neurochemistry International|August 7, 2013
(-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sitesHugo R Arias, Marcelo O Ortells, Dominik Feuerbach
Neurochemistry International|September 11, 2016
Bupropion and its photoreactive analog (±)-SADU-3-72 interact with luminal and non-luminal sites at human α4β2 nicotinic acetylcholine receptorsHugo R Arias, Dominik Feuerbach, Marcelo O Ortells
The International Journal of Biochemistry & Cell Biology|January 19, 2010
Inhibitory mechanisms and binding site location for serotonin selective reuptake inhibitors on nicotinic acetylcholine receptorsHugo R Arias, Dominik Feuerbach, Pankaj Bhumireddy, et al.
Journal of Natural Products|July 6, 2019
Alkaloids Purified from <i>Aristotelia chilensis</i> Inhibit the Human α3β4 Nicotinic Acetylcholine Receptor with Higher Potencies Compared with the Human α4β2 and α7 SubtypesHugo R Arias, Marcelo O Ortells, Dominik Feuerbach, et al.
Molecules (Basel, Switzerland)|April 30, 2021
Is the Antidepressant Activity of Selective Serotonin Reuptake Inhibitors Mediated by Nicotinic Acetylcholine Receptors?Hugo R Arias, Katarzyna M Targowska-Duda, Jesús García-Colunga, et al.
Journal of Natural Products|April 11, 2018
Drimane Sesquiterpenoids Noncompetitively Inhibit Human α4β2 Nicotinic Acetylcholine Receptors with Higher Potency Compared to Human α3β4 and α7 SubtypesHugo R Arias, Dominik Feuerbach, Bernd Schmidt, et al.
Pageof 3